Feinstein Awarded $3.4 Million From Wellcome To Test Schizophrenia Treatment rTMS

The Feinstein Institutes for Medical Research was awarded a $3.4 million grant by Wellcome for a study using repetitive transcranial stimulation (rTMS) to treat schizophrenia. The study will test whether rTMS improves social cognitive performance of people living with schizophrenia over the course of five years. Wellcome is a London-based charitable foundation which focuses on funding health research.

Already approved by the U.S. Food and Drug Administration (FDA), rTMS is used to help treat people with depression and obsessive-compulsive disorder (OCD). When rTMS is used, an electromagnetic coil is placed against a patient’s head. The . . .